Nasovap100 ml

Nasovap is an over-the-counter topical preparation indicated for:

• Established/OTC-monograph use: Temporary relief of nasal and sinus congestion associated with the common cold, when applied to the chest, throat, or back, or used as a steam inhalant.
• Established/OTC-monograph use: Temporary relief of minor aches and pains of muscles and joints associated with simple backache, muscle strain, or minor sprains, used as a topical counterirritant rub.
• Symptomatic/adjunct use: As an inhalant (a few drops added to hot water for steam inhalation) to provide a subjective sensation of easier breathing during upper respiratory tract congestion.

Nasovap provides symptomatic relief only; it does not treat the underlying cause of infection or shorten the duration of a cold.

Each unit of Menthol + Eucalyptus Oil topical preparation typically contains:

• Menthol (a topical counterirritant/analgesic derived from mint oils)
• Eucalyptus Oil (a volatile aromatic oil, primarily containing eucalyptol/cineole)

Menthol + Eucalyptus Oil is generally formulated as an ointment, balm, liquid rub, or inhalant preparation for external/topical use only. Exact strengths vary by brand; refer to the specific product label for the precise concentration of each component.

Nasovap is a combination topical/inhalant product combining two well-known aromatic agents used for generations in over-the-counter cold and cough remedies.

Menthol produces a cooling sensation on the skin and mucous membranes by stimulating cold-sensitive nerve receptors, and is used topically as a mild analgesic and counterirritant. Eucalyptus oil is an aromatic volatile oil that, when inhaled or applied topically, produces a sensation of clearer breathing and is traditionally used to ease the discomfort of nasal and chest congestion.

Nasovap is intended strictly for external use (topical application to intact skin) or as a steam inhalant, and is not intended for oral ingestion or application to broken skin, eyes, or mucous membranes.

Nasovap belongs to the therapeutic class of topical analgesics/counterirritants and over-the-counter cold and cough symptomatic-relief preparations (inhalant/rub type).

Mechanism of Action

Menthol + Eucalyptus Oil works through two complementary local mechanisms:

• Menthol selectively activates cold-sensitive TRPM8 receptors in the skin and nasal/oral mucosa, producing a cooling sensation and a mild local analgesic/counterirritant effect. When inhaled, menthol vapor stimulates these same cold receptors in the nasal passages, creating a subjective sensation of increased airflow and decongestion, without producing an actual measurable reduction in nasal airway resistance.
• Eucalyptus Oil (rich in cineole/eucalyptol) is a volatile aromatic compound that, when applied topically or inhaled as vapor, provides a warming/soothing counterirritant effect on the skin and a mild expectorant-like, decongestant sensation on the respiratory mucosa.

Both components act locally; systemic absorption through intact skin is minimal when Menthol + Eucalyptus Oil is used as directed.

Nasovap is for external (topical) use only, applied by gentle rubbing onto intact skin of the chest, throat, or back, or used as an inhalant added to hot water for steam inhalation. It must never be swallowed, and must not be applied inside the nostrils, in the mouth, near the eyes, or on broken or irritated skin.

Formal drug-interaction studies with Nasovap are lacking, as it is a topical, locally-acting OTC product with minimal systemic absorption. However, the following practical precautions are clinically relevant:

• Other topical counterirritants: Concurrent application of Nasovap with other menthol-, camphor-, or capsaicin-containing topical products on the same skin area is not recommended, as this may increase the risk of skin irritation or burns.
• Occlusive dressings/heating devices: Combining Nasovap with tight bandages or external heat sources (heating pads, hot water bottles) over the application site can increase systemic absorption and the risk of local tissue injury.

When used as directed, Nasovap is generally well tolerated. Reported side effects are almost exclusively local and include:

• Local skin irritation, redness, or a burning/stinging sensation at the site of application
• Contact dermatitis or allergic skin reaction in sensitized individuals
• Mild eye or mucous membrane irritation if the product is accidentally transferred to these areas

Discontinue use and consult a physician if a rash, excessive irritation, or signs of an allergic reaction develop. See Overdose Effects for risks associated with accidental ingestion.

There are no well-controlled clinical studies establishing the safety of Nasovap in human pregnancy or lactation. As a topically applied product with minimal expected systemic absorption when used as directed, the risk to a fetus or nursing infant is considered low; however, Nasovap should be used during pregnancy and breastfeeding only if clearly needed, in the smallest effective amount, and after consulting a physician, since potential benefit must be weighed against any potential risk. Avoid applying Nasovap to the breast area if breastfeeding, to prevent inadvertent ingestion by the infant.

• For external use only. Do not swallow Nasovap. Do not apply in or near the nostrils.
• Avoid contact with the eyes and other mucous membranes; if accidental contact occurs, rinse thoroughly with water.
• Do not apply to wounds, damaged skin, or irritated/broken skin.
• Do not bandage tightly or apply external heat over the area of application, as this may increase absorption and the risk of burns.
• Nasovap preparations containing volatile oils may be flammable; keep away from open flame, sparks, and heat sources.
• Not recommended for children under 2 years of age (see Contraindications and Use in Special Populations).
• Discontinue use and consult a physician if symptoms worsen, if irritation develops, or if cough/congestion persists beyond 7 days or is accompanied by fever, rash, or persistent headache.
• Keep Nasovap out of reach of children at all times, as accidental ingestion (particularly of eucalyptus oil) can be seriously toxic even in small amounts.

Nasovap is intended for external/topical use only and is not meant to be swallowed. Accidental ingestion, particularly of eucalyptus oil, can be seriously toxic, even in small volumes, and is more dangerous in young children.

Symptoms of ingestion may include nausea, vomiting, abdominal pain, dizziness, drowsiness, difficulty breathing, muscle weakness, or seizures, and can progress to loss of consciousness in severe cases.

If Nasovap is swallowed, or if excessive skin exposure causes systemic symptoms, seek immediate emergency medical attention or contact a poison control center right away. Do not attempt to induce vomiting or give any home remedy without professional medical guidance.

Store Nasovap at room temperature (below 30°C), away from light, heat, moisture, and open flame, as it may be flammable. Keep the container tightly closed and out of reach and sight of children.

• Infants and children under 2 years: Nasovap must not be used in this age group due to the risk of reflex apnea and laryngospasm from strong vapors (see Contraindications).
• Children 2 to 12 years: Use only under adult supervision, in the amounts and frequency directed on the product label; avoid application near the face and nostrils.
• Elderly patients: No specific dose adjustment is required, but elderly patients with thin or fragile skin should be monitored more closely for local irritation.
• Renal or hepatic impairment: No dose adjustment is required for topical use of Nasovap, as systemic absorption is minimal when used as directed.

Nasovap is intended for short-term, symptomatic use during an episode of common cold-related congestion or minor muscle ache, typically for a few days. If congestion, cough, or muscle pain persists beyond 7 days, worsens, or recurs, or if it is accompanied by fever, discontinue use and consult a physician.

Menthol + Eucalyptus Oil is classified as a topical analgesic/counterirritant and an over-the-counter inhalant/rub-type decongestant preparation used for symptomatic relief of common cold symptoms and minor musculoskeletal aches.

Menthol + Eucalyptus Oil acts locally at the site of application or inhalation. Menthol stimulates cutaneous and mucosal cold-sensitive (TRPM8) receptors, producing cooling, mild local analgesia, and a counterirritant effect that can distract from underlying pain; when inhaled, it produces a subjective sensation of improved nasal airflow. Eucalyptus oil, largely through its cineole content, provides a warming/soothing topical counterirritant action and, when inhaled as vapor, a mild decongestant and expectorant-like sensation on the airway mucosa. Neither component produces a true pharmacological reduction in nasal airway resistance or mucus viscosity; the benefit is primarily sensory/symptomatic.

Nasovap is contraindicated in infants and children younger than 2 years, because menthol and eucalyptus oil vapors applied near the nose and mouth in this age group have been associated with reflex apnea, laryngospasm, and breathing difficulty.

For children 2 to 12 years of age, Nasovap may be used topically only under adult supervision, in the amount and frequency directed on the product label, avoiding the face and nostrils. Safety and efficacy of routine steam-inhalant use have not been formally established in this age group beyond traditional OTC labeling, so parents/caregivers should consult a physician or pharmacist before use, particularly in children with asthma or other respiratory conditions.